Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epirubicin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03647280
What this trial is testing

The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Breast Cancer
Zhejiang Cancer Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00220129
What this trial is testing

Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus

Who this might be right for
Oesophageal Carcinoma
Royal Marsden NHS Foundation Trust 16
Very early researchStudy completedNCT00215514
What this trial is testing

Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Stomach CancerGastric CancerGastro-esophageal Junction Cancer
Dana-Farber Cancer Institute 25
Early research (Phase 1)Study completedNCT00722293
What this trial is testing

A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 111
Testing effectiveness (Phase 2)UnknownNCT00075465
What this trial is testing

Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach

Who this might be right for
Gastric Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Large-scale testing (Phase 3)Study completedNCT00002953
What this trial is testing

Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Medical Research Council 704
Large-scale testing (Phase 3)Study completedNCT00087178
What this trial is testing

Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 2,722
Large-scale testing (Phase 3)Study completedNCT00309556
What this trial is testing

Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer

Who this might be right for
Breast Cancer
Austrian Breast & Colorectal Cancer Study Group 536
Testing effectiveness (Phase 2)Study completedNCT00548899
What this trial is testing

Neoadjuvant Chemotherapy Including Sorafenib in Women With Previously Untreated Primary Breast Cancer

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 36
Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Testing effectiveness (Phase 2)Study completedNCT00795899
What this trial is testing

Taxol Epirubicin Cyclophosphamide Herceptin Neoadjuvant (TECHNO)

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 230
Testing effectiveness (Phase 2)Study completedNCT00737438
What this trial is testing

Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center 22
Testing effectiveness (Phase 2)Ended earlyNCT01123473
What this trial is testing

Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionGastric Cancer
European Organisation for Research and Treatment of Cancer - EORTC 29
Large-scale testing (Phase 3)UnknownNCT03876886
What this trial is testing

The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency

Who this might be right for
Triple Negative Breast Cancer
Chinese Academy of Medical Sciences 200
Not applicableStudy completedNCT00907543
What this trial is testing

Quality of Life in Neoadjuvant Versus Adjuvant Therapy of Esophageal Cancer Treatment Trial

Who this might be right for
Esophageal Neoplasms
Richard Malthaner 96
Large-scale testing (Phase 3)Ended earlyNCT00824785
What this trial is testing

REAL3 Trial of Efficacy of EOX With/Without Panitumumab in Previously Untreated Adv OG Cancer

Who this might be right for
Oesophago-gastric Cancer
Royal Marsden NHS Foundation Trust 574
Large-scale testing (Phase 3)Study completedNCT01433614
What this trial is testing

Epirubicin and Paclitaxel, Alone or Together With Capecitabine as First Line Treatment in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Thomas Hatschek 304
Testing effectiveness (Phase 2)Study completedNCT00755976
What this trial is testing

Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Melanoma (Skin)
Cancer Trials Ireland 32
Large-scale testing (Phase 3)Study completedNCT00424606
What this trial is testing

Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer Patients

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 658
Testing effectiveness (Phase 2)Study completedNCT01869192
What this trial is testing

Phase II Trial for Large ER-Negative Breast Cancers

Who this might be right for
Malignant Neoplasm of Female Breast
University of Colorado, Denver 72
Next Page